Medscape
- Medscape ( Middle East ) 2025/3/31
Vestibular therapy is feasible and may alleviate dizziness symptoms among patients in the emergency department, a pilot study finds. Meds...
- Medscape ( Middle East ) 2025/3/31
The modified vaccinia Ankara-Bavarian Nordic vaccine, originally approved for smallpox, is safe and well tolerated in at-risk individuals, w...
- Medscape ( Middle East ) 2025/3/31
New findings suggest that resorcinol may disrupt hormone systems and cause serious health issues, prompting regulatory action to safeguard p...
- Medscape ( Middle East ) 2025/3/31
A patient survey highlights significant barriers to narrowband UVB phototherapy among children with vitiligo, including limited availability...
- Medscape ( Middle East ) 2025/3/31
Echocardiography is independently associated with survival time and readmission rates in patients with type 2 diabetes. Medscape Medical...
- Medscape ( Middle East ) 2025/3/31
Adults using their phones before bed have an increased rate of poor sleep and sleep disruptions, a new study finds. Medscape Medical News
- Medscape ( Middle East ) 2025/3/31
Aspirin use is associated with an increased risk for acute kidney injury in critical patients with chest trauma, whereas ibuprofen and ketor...
- Medscape ( Middle East ) 2025/3/31
A newly identified genetic signature is associated with improved survival in high-risk myeloid neoplasms. Medscape Medical News
- Medscape ( Middle East ) 2025/3/31
The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising concerns about the ris...
- Medscape ( Middle East ) 2025/3/31
The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor pathway inhibi...
- Medscape ( Middle East ) 2025/3/31
High malpractice costs, restrictive legislation, and rising burnout are driving Ob/Gyns out. What can be done? Medscape Medical News
- Medscape ( Middle East ) 2025/3/31
Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy and safety pro...
- Medscape ( Middle East ) 2025/3/31
Deficiency of the pancreatic progenitor cell differentiation and proliferation factor gene was identified as a risk factor for chronic kidne...
- Medscape ( Middle East ) 2025/3/31
Patients with MASLD had nearly twice the all-cause mortality rate as the general population, suggesting the need for multidisciplinary care...
- Medscape ( Middle East ) 2025/3/31
Advances in PCI over the past decade mean the procedure can now approximate results only previously achieved with open-heart bypass surgery,...
- Medscape ( Middle East ) 2025/3/30
Just as effective as the high dose, low-dose apixaban prevents long-term recurrent venous thromboembolism in patients with cancer, and lower...
- Medscape ( Middle East ) 2025/3/30
A show of hands at the ACC town hall demonstrated unity as specialists investigate options for a new certifying board outside the current on...
- Medscape ( Middle East ) 2025/3/30
Oral semaglutide, already approved for type 2 diabetes, led to a reduction in CV events in patients with established atherosclerotic disease...
- Medscape ( Middle East ) 2025/3/30
The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a practice-changing...
- Medscape ( Middle East ) 2025/3/29
The addition of the aldosterone synthase inhibitor helped lower blood pressure in patients with resistant hypertension. Medscape Medical...
- Medscape ( Middle East ) 2025/3/29
A Northwestern medical student has found a better way of measuring heart health by smartwatch using a formula of steps per day and heart rat...
- Medscape ( Middle East ) 2025/3/29
The novel RNA therapeutic targets antithrombin production in the liver. Medscape Medical News
- Medscape ( Middle East ) 2025/3/28
A UK study found that nearly 1 in 10 adverse drug reactions involve medications influenced by genetic factors, highlighting the need for wid...
- Medscape ( Middle East ) 2025/3/28
The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the treatment of Alzh...
- Medscape ( Middle East ) 2025/3/28
The benefits of naltrexone/bupropion (Mysimba) continue to outweigh its risks, despite ongoing uncertainty about long-term cardiovascular sa...